KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses

International Journal of Cancer

Volumn 127, Issue 10, 2010, Pages 2351-2359

  Demokan, Semra ^a   Chang, Xiaofei ^a   Chuang, Alice ^a   Mydlarz, Wojciech K ^a   Kaur, Jatinder ^b   Huang, Peng ^a,c   Khan, Zubair ^a   Khan, Tanbir ^a   Ostrow, Kimberly L ^a   Brait, Mariana ^a   Hoque, Mohammad O ^a   Liegeois, Nanette J ^a   Sidransky, David ^a   Koch, Wayne ^a   Califano, Joseph A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

EDNRB; head and neck cancer; KIF1A; methylation; saliva

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CD44 GENE; CDH4 GENE; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; EDNRB GENE; FEMALE; FKBP4 GENE; GENE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; KIF1A GENE; MAJOR CLINICAL STUDY; MAL GENE; MALE; NISCH GENE; PAK3 GENE; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; SALIVA ANALYSIS; SQUAMOUS CELL CARCINOMA; TERT GENE; TISSUE SECTION; VGF GENE; CASE CONTROL STUDY; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; SALIVA; SALIVARY GLAND;

ENDOTHELIN B RECEPTOR; KIF1A PROTEIN, HUMAN; KINESIN;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KINESIN; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RECEPTOR, ENDOTHELIN B; SALIVA; SALIVARY GLANDS; YOUNG ADULT;

EID: 78049491735     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25248     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ,. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30.
2. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA,. Predicting lung cancer by detecting aberrant promoter methylationinsputum. Cancer Res 2000; 60: 5954-8.
3. Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, Califano JA, Sidransky D,. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res 2004; 64: 5511-17.
4. Nunes DN, Kowalski LP, Simpson AJ,. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol 2000; 36: 525-8.
5. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D,. Promoter hypermethylation patterns of p16, O6-methylguanine- DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001; 61: 939-42.
6. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S, Goepfert H,. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 2001; 3: 164-70.
7. Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, Chang S, Brait M, Nayak CS, Jiang WW, Claybourne Q, Tokumaru Y, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008; 14: 97-107.
8. Lee A, Kim Y, Han K, Kang CS, Jeon HM, Shim SI,. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast. Arch Pathol Lab Med 2004; 128: 1251-6.
9. Usadel H, Brabender J, Danenberg KD, JerÃnimo C, Harden S, Engles J, Danenberg PV, Yang S, Sidransky D,. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002; 62: 371-5.
10. Hu S, Ewertz M, Tufano RP, Brait M, Carvalho AL, Liu D, Tufaro AP, Basaria S, Cooper DS, Sidransky D, Ladenson PW, Xing M,. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J Clin Endocrinol Metab 2006; 91: 98-104.
11. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG, Sidransky D,. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2000; 60: 892-5.
12. Wong IH, Zhang J, Lai PB, Lau WY, Lo YM,. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. Clin Cancer Res 2003; 9: 1047-52.
13. Wadsworth JT, Somers KD, Stack BC Jr., Cazares L, Malik G, Adam BL, Wright GL Jr., Semmes OJ,. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 2004; 130: 98-104.
14. Bernard PS, Wittwer CT,. Real-time PCR technology for cancer diagnostics. Clin Chem 2002; 48: 1178-85.
15. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW,. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28: E32.
16. Cottrell SE, Laird PW,. Sensitive detection of DNA methylation. Ann N Y Acad Sci 2003; 983: 120-30.
17. JerÃnimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG, Sidransky D,. Quantitation of GSTP1methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 2001; 93: 1747-52.
18. Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, Poeta ML, Jeronimo C, Henrique R, Lendvai A, Schuuring E, Begum S, et al. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 2008; 68: 2661-70.
19. Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA,. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate 2004; 60: 25-31.
20. Pu RT, Sheng ZM, Michael CW, Rhode MG, Clark DP, O'Leary TJ,. Methylation profiling of mesothelioma using real-time methylation-specific PCR: a pilot study. Diagn Cytopathol 2007; 35: 498-502.
21. Ostrow KL, Park HL, Hoque MO, Kim MS, Liu J, Argani P, Westra W, Van Criekinge W, Sidransky D,. Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin Cancer Res 2009; 15: 1184-91.
22. Park HL, Kim MS, Yamashita K, Westra W, Carvalho AL, Lee J, Jiang WW, Baek JH, Liu J, Osada M, Moon CS, Califano JA, et al. DCC promoter hypermethylation in esophageal squamous cell carcinoma. Int J Cancer 2008; 122: 2498-502.
23. Miotto E, Sabbioni S, Veronese A, Calin GA, Gullini S, Liboni A, Gramantieri L, Bolondi L, Ferrazzi E, Gafà R, Lanza G, Negrini M,. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res 2004; 64: 8156-9.
24. Okada Y, Yamazaki H, Sekine-Aizawa Y, Hirokawa N,. The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell 1995; 81: 769-80.
25. Yonekawa Y, Harada A, Okada Y, Funakoshi T, Kanai Y, Takei Y, Terada S, Noda T, Hirokawa N,. Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J Cell Biol 1998; 141: 431-41.
26. Smollich M, Wülfing P,. Targeting the endothelin system: novel therapeutic options in gynecological, urological and breast cancers. Expert Rev Anticancer Ther 2008; 8: 1481-93.
27. Yates DR, Rehman I, Abbod MF, Meuth M, Cross SS, Linkens DA, Hamdy FC, Catto JW,. Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 2007; 13: 2046-53.
28. Friedrich MG, Chandrasoma S, Siegmund KD, Weisenberger DJ, Cheng JC, Toma MI, Huland H, Jones PA, Liang G,. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. Eur J Cancer 2005; 41: 2769-78.
29. Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Sano F, Baba M, Kondo K, Nakaigawa N, Kishida T, Nagashima Y, Yamada-Okabe H, et al. A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma. Int J Cancer 2008; 123: 1126-32.
30. Rogers CG, Gonzalgo ML, Yan G, Bastian PJ, Chan DY, Nelson WG, Pavlovich CP,. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection. J Urol 2006; 176: 2280-4.
31. Chen SC, Lin CY, Chen YH, Fang HY, Cheng CY, Chang CW, Chen RA, Tai HL, Lee CH, Chou MC, Lin TS, Hsu LS,. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan. Oncol Rep 2006; 15: 167-72.
32. Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, Ellison DW, Clifford SC,. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling. Carcinogenesis 2004; 25: 661-8.
33. Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY,. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep 2006; 15: 507-11.
34. Lo KW, Tsang YS, Kwong J, To KF, Teo PM, Huang DP,. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer 2002; 98: 651-5.
35. Zhou L, Feng X, Shan W, Zhou W, Liu W, Wang L, Zhu B, Yi H, Yao K, Ren C,. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma. Oncology 2007; 72: 357-63.